These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 38188524)

  • 21. A cre-inducible DUX4 transgenic mouse model for investigating facioscapulohumeral muscular dystrophy.
    Jones T; Jones PL
    PLoS One; 2018; 13(2):e0192657. PubMed ID: 29415061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facioscapulohumeral dystrophy: activating an early embryonic transcriptional program in human skeletal muscle.
    Campbell AE; Belleville AE; Resnick R; Shadle SC; Tapscott SJ
    Hum Mol Genet; 2018 Aug; 27(R2):R153-R162. PubMed ID: 29718206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-Catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy.
    Banerji CR; Knopp P; Moyle LA; Severini S; Orrell RW; Teschendorff AE; Zammit PS
    J R Soc Interface; 2015 Jan; 12(102):20140797. PubMed ID: 25551153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DUX4 Signalling in the Pathogenesis of Facioscapulohumeral Muscular Dystrophy.
    Lim KRQ; Nguyen Q; Yokota T
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Targeted Approach for Evaluating DUX4-Regulated Proteins as Potential Serum Biomarkers for Facioscapulohumeral Muscular Dystrophy Using Immunoassay Proteomics.
    Campbell AE; Arjomand J; King OD; Tawil R; Jagannathan S
    J Neuromuscul Dis; 2023; 10(6):1031-1040. PubMed ID: 37899061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of
    Lim KRQ; Maruyama R; Echigoya Y; Nguyen Q; Zhang A; Khawaja H; Sen Chandra S; Jones T; Jones P; Chen YW; Yokota T
    Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16509-16515. PubMed ID: 32601200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perm1 regulates CaMKII activation and shapes skeletal muscle responses to endurance exercise training.
    Cho Y; Tachibana S; Hazen BC; Moresco JJ; Yates JR; Kok B; Saez E; Ross RS; Russell AP; Kralli A
    Mol Metab; 2019 May; 23():88-97. PubMed ID: 30862473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. It's not all about muscle: fibroadipogenic progenitors contribute to facioscapulohumeral muscular dystrophy.
    Serra C; Wagner KR
    J Clin Invest; 2020 May; 130(5):2186-2188. PubMed ID: 32250345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profiling Serum Antibodies Against Muscle Antigens in Facioscapulohumeral Muscular Dystrophy Finds No Disease-Specific Autoantibodies.
    Greco A; Straasheijm KR; Mul K; van den Heuvel A; van der Maarel SM; Joosten LAB; van Engelen BGM; Pruijn GJM
    J Neuromuscul Dis; 2021; 8(5):801-814. PubMed ID: 34024774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene.
    Snider L; Geng LN; Lemmers RJ; Kyba M; Ware CB; Nelson AM; Tawil R; Filippova GN; van der Maarel SM; Tapscott SJ; Miller DG
    PLoS Genet; 2010 Oct; 6(10):e1001181. PubMed ID: 21060811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated Nicotinamide Phosphoribosyl Transferase in Skeletal Muscle Augments Exercise Performance and Mitochondrial Respiratory Capacity Following Exercise Training.
    Brouwers B; Stephens NA; Costford SR; Hopf ME; Ayala JE; Yi F; Xie H; Li JL; Gardell SJ; Sparks LM; Smith SR
    Front Physiol; 2018; 9():704. PubMed ID: 29942262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD).
    Jones TI; Parilla M; Jones PL
    PLoS One; 2016; 11(3):e0150938. PubMed ID: 26942723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WDR5 is required for DUX4 expression and its pathological effects in FSHD muscular dystrophy.
    Mocciaro E; Giambruno R; Micheloni S; Cernilogar FM; Andolfo A; Consonni C; Pannese M; Ferri G; Runfola V; Schotta G; Gabellini D
    Nucleic Acids Res; 2023 Jun; 51(10):5144-5161. PubMed ID: 37021550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apabetalone, a Clinical-Stage, Selective BET Inhibitor, Opposes DUX4 Target Gene Expression in Primary Human FSHD Muscle Cells.
    Sarsons CD; Gilham D; Tsujikawa LM; Wasiak S; Fu L; Rakai BD; Stotz SC; Carestia A; Sweeney M; Kulikowski E
    Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37893058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-cell RNA sequencing in facioscapulohumeral muscular dystrophy disease etiology and development.
    van den Heuvel A; Mahfouz A; Kloet SL; Balog J; van Engelen BGM; Tawil R; Tapscott SJ; van der Maarel SM
    Hum Mol Genet; 2019 Apr; 28(7):1064-1075. PubMed ID: 30445587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DUX4 promotes transcription of FRG2 by directly activating its promoter in facioscapulohumeral muscular dystrophy.
    Thijssen PE; Balog J; Yao Z; Pham TP; Tawil R; Tapscott SJ; Van der Maarel SM
    Skelet Muscle; 2014; 4():19. PubMed ID: 25789155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Epigenetic Regulators of DUX4-fl for Targeted Therapy of Facioscapulohumeral Muscular Dystrophy.
    Himeda CL; Jones TI; Virbasius CM; Zhu LJ; Green MR; Jones PL
    Mol Ther; 2018 Jul; 26(7):1797-1807. PubMed ID: 29759937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of candidate miRNA biomarkers for facioscapulohumeral muscular dystrophy using DUX4-based mouse models.
    Nunes AM; Ramirez M; Jones TI; Jones PL
    Dis Model Mech; 2021 Aug; 14(8):. PubMed ID: 34338285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7.
    Banerji CRS; Zammit PS
    EMBO Mol Med; 2021 Aug; 13(8):e13695. PubMed ID: 34151531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of DUX4 in zebrafish development recapitulates facioscapulohumeral muscular dystrophy.
    Mitsuhashi H; Mitsuhashi S; Lynn-Jones T; Kawahara G; Kunkel LM
    Hum Mol Genet; 2013 Feb; 22(3):568-77. PubMed ID: 23108159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.